Market Insights Consumer OTC Pharmaceuticals

Eye Care - Japan

Japan

Revenue in the Eye Care market amounts to US$0.96bn in 2024. The market is expected to grow annually by 2.95% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (US$1,256m in 2024).
In relation to total population figures, per person revenues of US$7.81 are generated in 2024.

Key regions: Thailand, Philippines, Indonesia, Canada, United Kingdom

Market

Region

Region comparison

Currency

Analyst Opinion

The Eye Care market in Japan is experiencing significant growth and development driven by various factors.

Customer preferences: Japanese consumers have become increasingly concerned about their eye health and are placing a greater emphasis on preventive measures. This shift in consumer preferences is driven by a growing awareness of the importance of eye care and the desire to maintain good vision. Additionally, an aging population in Japan has resulted in a higher prevalence of age-related eye conditions, further driving the demand for eye care products and services.

Trends in the market: One major trend in the Eye Care market in Japan is the increasing popularity of contact lenses. Contact lenses offer convenience and comfort compared to traditional eyeglasses, and they are particularly favored by younger consumers who value aesthetics and an active lifestyle. The demand for contact lenses is also driven by technological advancements, such as the development of silicone hydrogel lenses that provide enhanced comfort and breathability. Another trend in the market is the growing demand for specialized eye care products. Japanese consumers are seeking products that address specific eye conditions, such as dry eyes or eye strain caused by excessive screen time. This has led to the introduction of innovative products, including eye drops with moisturizing properties and blue light-blocking glasses.

Local special circumstances: Japan has a well-established healthcare system that provides easy access to eye care services. The country has a large number of ophthalmologists and optometrists, ensuring that consumers can receive regular eye examinations and necessary treatments. This accessibility to eye care professionals contributes to the overall growth of the Eye Care market in Japan.

Underlying macroeconomic factors: The aging population in Japan is a significant macroeconomic factor that drives the growth of the Eye Care market. As people age, the risk of developing eye conditions such as cataracts, glaucoma, and age-related macular degeneration increases. This demographic trend creates a larger customer base for eye care products and services. Furthermore, Japan has a high disposable income per capita, allowing consumers to afford premium eye care products and services. The willingness to spend on quality eye care contributes to the growth of the market and encourages innovation in the industry. In conclusion, the Eye Care market in Japan is experiencing growth and development due to changing customer preferences, including a focus on preventive eye care and the popularity of contact lenses. The market is also influenced by local special circumstances, such as the accessibility of eye care services, and underlying macroeconomic factors, such as an aging population and high disposable income. These factors contribute to the overall expansion of the Eye Care market in Japan.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.